ConductScience.org, home

Paper36978398

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.

Martínez-Casanova J and 12 others. Antibiotics (Basel), 2023. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients. Papers, record 36978398. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978398

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2023-03-31
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martínez-Casanova JJavier
2Esteve-Pitarch EErikahttps://orcid.org/0000-0003-3534-3460
3Colom-Codina HHelena
4Gumucio-Sanguino VDVíctor Daniel
5Cobo-Sacristán SSara
6Shaw EEvelynhttps://orcid.org/0000-0002-1882-1259
7Maisterra-Santos KKristel
8Sabater-Riera JJoan
9Pérez-Fernandez XLXosé Lhttps://orcid.org/0000-0002-5903-6927
10Rigo-Bonnin RRaül
11Tubau-Quintano FFe
12Carratalà JJordihttps://orcid.org/0000-0003-3209-2563
13Padullés-Zamora AAriadna

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126754759
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
Intensive Care Med2016https://conductscience.org/library/papers/26754759PubMed
233042550
Prolonged versus intermittent β-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials.
J Intensive Care2020https://conductscience.org/library/papers/33042550PubMed
334131869Continuous Infusion of Piperacillin/Tazobactam and Meropenem in ICU Patients Without Renal Dysfunction: Are Patients at Risk of Underexposure?Eur J Drug Metab Pharmacokinet2021https://conductscience.org/library/papers/34131869PubMed
417785973Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion.Chemotherapy2007https://conductscience.org/library/papers/17785973PubMed
523074313Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.Clin Infect Dis2013https://conductscience.org/library/papers/23074313PubMed
621302010Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.AAPS J2011https://conductscience.org/library/papers/21302010PubMed
722194591Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.Chest2012https://conductscience.org/library/papers/22194591PubMed
827476810Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients.Int J Antimicrob Agents2016https://conductscience.org/library/papers/27476810PubMed
919237898Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?Crit Care Med2009https://conductscience.org/library/papers/19237898PubMed
1019252334Mechanistic basis of using body size and maturation to predict clearance in humans.Drug Metab Pharmacokinet2009https://conductscience.org/library/papers/19252334PubMed
1126200166A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.Am J Respir Crit Care Med2015https://conductscience.org/library/papers/26200166PubMed
1225038549The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.Adv Drug Deliv Rev2014https://conductscience.org/library/papers/25038549PubMed
1328571493Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?Expert Rev Anti Infect Ther2017https://conductscience.org/library/papers/28571493PubMed
1424768475Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.Lancet Infect Dis2014https://conductscience.org/library/papers/24768475PubMed
1525881576A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics.Crit Care2015https://conductscience.org/library/papers/25881576PubMed
166225390Pharmacokinetics of piperacillin in subjects with various degrees of renal function.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6225390PubMed
1729102324Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials.Lancet Infect Dis2018https://conductscience.org/library/papers/29102324PubMed
1829791023Comparison of the Cockcroft-Gault, MDRD and CKD-EPI equations for estimating ganciclovir clearance.Br J Clin Pharmacol2018https://conductscience.org/library/papers/29791023PubMed
1916023764PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.Comput Methods Programs Biomed2005https://conductscience.org/library/papers/16023764PubMed
2025643277Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development.Semin Respir Crit Care Med2015https://conductscience.org/library/papers/25643277PubMed

See all 56 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42171260Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring.Anal Methods2026https://conductscience.org/library/papers/42171260PubMed
41858912Population Pharmacokinetics and Dosing Regimen Optimization of Piperacillin in Critically Ill Patients.Drug Des Devel Ther2026https://conductscience.org/library/papers/41858912PubMed
40001445Interprofessional Therapeutic Drug Monitoring of Piperacillin/Tazobactam Enhances Care for Patients with Acute-on-Chronic Liver Failure in the ICU: A Retrospective Observational Pilot Study.Antibiotics (Basel)2025https://conductscience.org/library/papers/40001445PubMed
39992534
Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints.
Eur J Clin Microbiol Infect Dis2025https://conductscience.org/library/papers/39992534PubMed
39473921Serum Concentration at 24 h With Intensive Beta-Lactam Therapy in Sepsis and Septic Shock: A Prospective Study: Beta-Lactam Blood Levels in Sepsis.Crit Care Res Pract2024https://conductscience.org/library/papers/39473921PubMed
39334976Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review.Antibiotics (Basel)2024https://conductscience.org/library/papers/39334976PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CTRC11330PubTator's text mininghttps://conductscience.org/library/genes/11330NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36978398

GET https://conductscience.org/api/papers/v1/36978398/references?page=2